| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2049312 | FEBS Letters | 2010 | 8 Pages |
Abstract
A new concept, that “metabolic disorders, such as type 2 diabetes, are membrane microdomain disorders caused by aberrant expression of gangliosides”, has arisen. By examining this working hypothesis, we demonstrate the molecular pathogenesis of type 2 diabetes and insulin resistance focusing on the interaction between insulin receptor and gangliosides in microdomains and propose the new therapeutic strategy “membrane microdomain ortho-signaling therapy”.
Related Topics
Life Sciences
Agricultural and Biological Sciences
Plant Science
Authors
Jin-ichi Inokuchi,